Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
Sales | 7,158,000 | 6,989,000 | 7,161,000 | 4,506,000 | 3,330,000 |
Cost of Goods | 1,221,000 | 1,180,000 | 1,236,000 | 697,000 | 809,000 |
Gross Profit | 5,937,000 | 5,809,000 | 5,925,000 | 3,809,000 | 3,183,000 |
Operating Expenses | 4,180,000 | 4,341,000 | 5,632,000 | 2,504,000 | 2,166,000 |
Operating Income | 1,757,000 | 1,468,000 | 293,000 | 1,305,000 | 355,000 |
Other Income | 28,000 | 199,000 | 117,000 | -1,000 | 612,000 |
Pre-tax Income | 1,785,000 | 1,667,000 | 410,000 | 1,304,000 | 967,000 |
Income Tax | 421,000 | 513,000 | 613,000 | 348,000 | 265,000 |
Net Income Continuous | 1,361,000 | 1,150,000 | -204,000 | 954,000 | 515,000 |
Net Income Discontinuous | N/A | N/A | N/A | 0 | 882,000 |
Net Income | $1,361,000 | $1,150,000 | $-204,000 | $954,000 | $1,397,000 |
EPS Basic Total Ops | 0.22 | 0.18 | -0.03 | 0.25 | 0.19 |
EPS Basic Continuous Ops | 0.22 | 0.18 | -0.03 | 0.25 | 0.14 |
EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.24 |
EPS Diluted Total Ops | 0.21 | 0.18 | -0.03 | 0.25 | 0.36 |
EPS Diluted Continuous Ops | 0.21 | 0.18 | -0.03 | 0.25 | 0.13 |
EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.23 |
EBITDA(a) | $1,991,000 | $1,697,000 | $537,000 | $1,466,000 | $492,000 |